CVE-2024-44167

Exploitation

Assessed, none found. CISA's assessment recorded neither public exploit code nor evidence of exploitation when it was made.

SSVC decision

• ExploitationnoneCISA recorded no public exploit code and no evidence of exploitation.
• AutomatablenoAt least one step from reconnaissance to exploitation cannot be reliably automated.
• Technical ImpacttotalSuccessful exploitation gives total control of the vulnerable component.

CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.

EPSS probability

0.63% probability of exploitation activity in the next 30 days.

EPSS percentile

Ranks above 47.3% of scored records. A rank, not a probability.

NVD base score

5.5 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N

NVD analysis status

Modified. NVD last modified this record on 2026-06-17.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2024-09-16 23:22Z1 YR AGO

Last updated

2026-04-02 18:11Z5 MO AGO

Reserved

2024-08-20

Assigning CNA

apple

Record state

PUBLISHED

Severity

High (CVSS 8.1)

CNA CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:N

Weaknesses

• CWE-22Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')Base

Data version

5.2

Document digest

e2850e4d537000fde2f0566ef3fedd43f888cf8a40ae929fe57762ca74de1ba6

• support.apple.comhttps://support.apple.com/en-us/121234
• support.apple.comhttps://support.apple.com/en-us/121238
• support.apple.comhttps://support.apple.com/en-us/121247
• support.apple.comhttps://support.apple.com/en-us/121249
• support.apple.comhttps://support.apple.com/en-us/121250
• seclists.orghttp://seclists.org/fulldisclosure/2024/Sep/40
• seclists.orghttp://seclists.org/fulldisclosure/2024/Sep/36
• seclists.orghttp://seclists.org/fulldisclosure/2024/Sep/33
• seclists.orghttp://seclists.org/fulldisclosure/2024/Sep/41
• seclists.orghttp://seclists.org/fulldisclosure/2024/Sep/32